Atlas Trials

The Impact Of SGLT2 -I on Metabolic Dysfunction -Associated Steatotic Liver Disease In Patients With Type 2 Diabetes Mellitus

Clinical trial NCT06117137 · COMPLETED

Trial details

NCT number
NCT06117137
Sponsor
Sohag University
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Fatty Liver, Nonalcoholic
Start date
2023-11-15
Primary completion
2025-01-01
Enrollment
150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.